MannKind Corp. (MNKD)

[TREND1]

MNKD UPDATE

1 REV = 0
2 AFREZZA (70% HIGHER) still at tier 3 insurance.
3 No FDA approval FOR NEW LABEL for AFREZZA. A1C THE SAME per FDA.
4 10 fold increase in AFREZZA SCRIPS/WEEK = BREAK EVEN post 15883
5 TV AD for AFREZZA post 15871
6 NO NEW bonus of 25 million from SNY.
7 NO completion of lung cancer study promised FDA
8 NO second drug being produced. Are other companies cheaper ?
9 RBC downgrades MNKD. Price target $1 see post 15775
10 Sanofi will stay connected to MNKD post 15873
11 MNKD in buy area post 15816